These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18227733)
1. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome. Nassar A; Lawson D; Cotsonis G; Cohen C Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733 [TBL] [Abstract][Full Text] [Related]
2. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis. Nassar A; Sexton D; Cotsonis G; Cohen C Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249 [TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of survivin in breast cancer. Kennedy SM; O'Driscoll L; Purcell R; Fitz-Simons N; McDermott EW; Hill AD; O'Higgins NJ; Parkinson M; Linehan R; Clynes M Br J Cancer; 2003 Apr; 88(7):1077-83. PubMed ID: 12671708 [TBL] [Abstract][Full Text] [Related]
4. Expression of survivin and clinical correlation in patients with breast cancer. Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381 [TBL] [Abstract][Full Text] [Related]
5. Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Fields AC; Cotsonis G; Sexton D; Santoianni R; Cohen C Mod Pathol; 2004 Nov; 17(11):1378-85. PubMed ID: 15195112 [TBL] [Abstract][Full Text] [Related]
6. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma. Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896 [TBL] [Abstract][Full Text] [Related]
7. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of survivin expression in primary breast cancers. Chu JS; Shew JY; Huang CS J Formos Med Assoc; 2004 Dec; 103(12):925-31. PubMed ID: 15624042 [TBL] [Abstract][Full Text] [Related]
9. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Tsai WC; Chu CH; Yu CP; Sheu LF; Chen A; Chiang H; Jin JS Dis Markers; 2008; 24(2):89-99. PubMed ID: 18219094 [TBL] [Abstract][Full Text] [Related]
10. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Hinnis AR; Luckett JC; Walker RA Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of survivin in breast carcinoma: relationship with clinicopathological parameters, proliferation and molecular classification. Youssef NS; Hewedi IH; Abd Raboh NM J Egypt Natl Canc Inst; 2008 Dec; 20(4):348-57. PubMed ID: 20571593 [TBL] [Abstract][Full Text] [Related]
12. Correlation between survivin expression and prognosis in non-small cell lung cancer. Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973 [TBL] [Abstract][Full Text] [Related]
13. COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome. Nassar A; Radhakrishnan A; Cabrero IA; Cotsonis G; Cohen C Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):255-9. PubMed ID: 17721268 [TBL] [Abstract][Full Text] [Related]
14. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648 [TBL] [Abstract][Full Text] [Related]
16. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
17. Survivin expression in breast lobular carcinoma: correlations with normal breast tissue and clinicomorphological parameters. Adamkov M; Výbohová D; Horáček J; Kovalská M; Furjelová M Acta Histochem; 2013 Jun; 115(5):412-7. PubMed ID: 23219440 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981 [TBL] [Abstract][Full Text] [Related]
19. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993 [TBL] [Abstract][Full Text] [Related]
20. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Kleinberg L; Flørenes VA; Nesland JM; Davidson B Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]